VOYA Investment Management
IMCR icon

VOYA Investment Management’s Immunocore IMCR Stock Holding History

VOYA Investment Management’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-18,550
Closed -$577K – 2758
2024
Q3 		$577K Hold
18,550
– – ﹤0.01% 1920
2024
Q2 		$629K Sell
18,550
-97,745
-84% -$4.99M ﹤0.01% 1879
2024
Q1 		$7.56M Sell
116,295
-2,970
-2% -$204K 0.01% 844
2023
Q4 		$8.15M Buy
119,265
+63,150
+113% +$3.28M 0.01% 817
2023
Q3 		$2.91M Buy
56,115
+5,125
+10% +$303K ﹤0.01% 1181
2023
Q2 		$3.06M Buy
50,990
+25,925
+103% +$1.48M ﹤0.01% 1184
2023
Q1 		$1.24M Buy
25,065
+11,395
+83% +$641K ﹤0.01% 1546
2022
Q4 		$780K Buy
+13,670
New +$769K ﹤0.01% 1773

Other funds holding IMCR

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

VOYA Investment Management's IMCR Position: Q4 2024 in Review

VOYA Investment Management sold out of Immunocore (IMCR) in Q4 2024, closing a stake of 18,550 shares — an estimated $577K sold.

VOYA Investment Management first reported a position in IMCR in Q4 2022 and held it in 8 quarters. The position peaked at $8.15M in Q4 2023. 115 funds tracked by Wall St. Rank hold IMCR as of Q4 2024.

  • VOYA Investment Management reported no remaining Immunocore position as of Q4 2024 after selling out during the quarter.
  • VOYA Investment Management sold 18,550 Immunocore shares in Q4 2024, an estimated $577K.
  • VOYA Investment Management first reported a position in Immunocore in Q4 2022 and held it in 8 quarters.
  • VOYA Investment Management's Immunocore position peaked at $8.15M in Q4 2023.
  • 115 funds tracked by Wall St. Rank held Immunocore as of Q4 2024.

Based on VOYA Investment Management's 13F filing for Q4 2024, filed 14 Feb 2025.